Cargando…

Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?

Lung cancer is notably a significant threat when considering worldwide cancer-related deaths. Despite significant advances in treatment modalities, death rates as a result of cancer relapse remain high. Relapse can occur as a result of metastasis. Cancer stem cells (CSCs) have been implicated as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Crous, Anine M, Abrahamse, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854767/
https://www.ncbi.nlm.nih.gov/pubmed/24153107
http://dx.doi.org/10.1186/scrt340
_version_ 1782294856880619520
author Crous, Anine M
Abrahamse, Heidi
author_facet Crous, Anine M
Abrahamse, Heidi
author_sort Crous, Anine M
collection PubMed
description Lung cancer is notably a significant threat when considering worldwide cancer-related deaths. Despite significant advances in treatment modalities, death rates as a result of cancer relapse remain high. Relapse can occur as a result of metastasis. Cancer stem cells (CSCs) have been implicated as an important contributory factor in the development of metastasis. CSCs have the same characteristics as normal stem cells; that is, they can proliferate indefinitely and are capable of both self-renewal and differentiating into specialized cells. The molecular and cellular characteristics of stem cells and CSCs are coded for by cell-specific genes, which can be analyzed by using molecular assays setting the standard to work from. Low-intensity laser irradiation (LILI) has been applied in the treatment of numerous diseases and pathological conditions. LILI has been shown to stimulate proliferation of cells, capillary growth, and cellular metabolism as observed by adenosine triphosphate activation. It has been shown, by using different dosing levels of LILI, to either stimulate or inhibit cellular functions. One treatment strategy used on cancer cells is photodynamic therapy (PDT), in which cancer cells are treated with a photosensitizer (PS) in combination with laser irradiation. PSs are non-toxic by themselves but, with light activation, cause reactive oxygen species generation, which causes cancer cell death. Cell-specific PSs are being developed for future cancer treatment. In this review, we look at the potential effects of LILI and PDT on lung CSCs.
format Online
Article
Text
id pubmed-3854767
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38547672014-10-23 Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy? Crous, Anine M Abrahamse, Heidi Stem Cell Res Ther Review Lung cancer is notably a significant threat when considering worldwide cancer-related deaths. Despite significant advances in treatment modalities, death rates as a result of cancer relapse remain high. Relapse can occur as a result of metastasis. Cancer stem cells (CSCs) have been implicated as an important contributory factor in the development of metastasis. CSCs have the same characteristics as normal stem cells; that is, they can proliferate indefinitely and are capable of both self-renewal and differentiating into specialized cells. The molecular and cellular characteristics of stem cells and CSCs are coded for by cell-specific genes, which can be analyzed by using molecular assays setting the standard to work from. Low-intensity laser irradiation (LILI) has been applied in the treatment of numerous diseases and pathological conditions. LILI has been shown to stimulate proliferation of cells, capillary growth, and cellular metabolism as observed by adenosine triphosphate activation. It has been shown, by using different dosing levels of LILI, to either stimulate or inhibit cellular functions. One treatment strategy used on cancer cells is photodynamic therapy (PDT), in which cancer cells are treated with a photosensitizer (PS) in combination with laser irradiation. PSs are non-toxic by themselves but, with light activation, cause reactive oxygen species generation, which causes cancer cell death. Cell-specific PSs are being developed for future cancer treatment. In this review, we look at the potential effects of LILI and PDT on lung CSCs. BioMed Central 2013-10-23 /pmc/articles/PMC3854767/ /pubmed/24153107 http://dx.doi.org/10.1186/scrt340 Text en Copyright © 2013 Crous and Abrahamse; licensee BioMed Central Ltd.
spellingShingle Review
Crous, Anine M
Abrahamse, Heidi
Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?
title Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?
title_full Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?
title_fullStr Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?
title_full_unstemmed Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?
title_short Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?
title_sort lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854767/
https://www.ncbi.nlm.nih.gov/pubmed/24153107
http://dx.doi.org/10.1186/scrt340
work_keys_str_mv AT crousaninem lungcancerstemcellsandlowintensitylaserirradiationapotentialfuturetherapy
AT abrahamseheidi lungcancerstemcellsandlowintensitylaserirradiationapotentialfuturetherapy